EOLS

Conviction 74HealthcareScan · Thu, Sep 24, 2026

Evolus, Inc. (EOLS) closed at $7.87 (-1.69%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 45, RS Rating 89, -15.4% from its 52-week high, +17.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

EOLS$7.87-1.69%

ResistanceSupportVol 14

Vol MA14 809.15K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Evolus, Inc.PHARMACEUTICAL PREPARATIONSwww.evolus.com ↗

Price7.87

Change-1.69%

Gap+0.31%

Rel volume0.60×

Avg volume835.57K

Avg $ vol7.08M

SMA 208.42

SMA 507.61

SMA 2006.14

Price vs 50+3.33%

Price vs 200+28.18%

MA stackbullish

50/200 cross—

Supertrenddown · 8.97

RSI (14)45

MACD hist-0.11

MACD cross—

Stoch %K / %D16 / 26

ADX (14)24

+DI / −DI23 / 20

RSI divergence—

MACD divergence—

ATR %4.75%

ADR %4.19%

52w high9.30

52w low3.94

From 52w high-15.43%

Above 52w low+99.62%

New 52w highNo

SqueezeOff

Bollinger width25.11%

%B0.24

Donchian pos15.99%

Donchian high9.31

Donchian low7.59

AVWAP (52w high)8.25

vs AVWAP high-4.72%

AVWAP (52w low)6.75

vs AVWAP low+16.47%

OBV trendDown

Chaikin MF (20)0.09

Today vs 20d0.60×

Avg vol (14d)809.15K

Avg vol (20d)835.57K

Avg $ vol (20d)7.08M

Market cap519.49M

RS Rating89 / 99

RS 3m (vs SPY)+5.51%

RS 6m (vs SPY)+63.16%

RS line new highNo

Trend template8/8

Technical rank77.5

1 week-1.81%

1 month-12.37%

3 months+10.00%

6 months+79.98%

1 year+27.06%

YTD+17.04%

P/E-10.06

P/B-16.81

P/S1.75

P/FCF-11.37

EPS-0.8000

Div yield—

ROE167.11%

ROA-20.82%

Debt/Eq-5.07

Current1.70

EV/EBITDA-25.09

Gross margin66.33%

Net margin-17.38%

Rev growth11.61%

EPS growth-2.42%

Price target14.33

Target upside82.20%

Analyst ratingBuy

Institutional78.22%

Ent. value631.06M

Revenue84.08M

Net income-8.05M

Gross profit57.18M

Free cash flow-45.71M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out65.85M

Employees350

ListedThu, Feb 8, 2018

Free float52.47M

Float %79.7%

Short interest5.37M

Days to cover5.2d

Short volume70.0%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.09 vs −$0.09

Last surprise0.0% beat

Setup gradeB

Conviction74 / 100

Pattern quality—

Tech rank77.5 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance9.23

Support7.66

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EOLS

All disclosures →

No recent disclosed trades by Congress in EOLS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EOLS

No recent insider (Form 4) filings in EOLS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in EOLS · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.